Objective. To compare two radiofrequency (RF) devices, Simplicity III (conventional RF), and SInergy (cooled RF), which are specifically designed to denervate the sacroiliac joint (SIJ).
Introduction
Sacroiliac joint (SIJ) pain is one of the most common origins of low back pain (LBP), accounting for an estimated 17-27% of chronic mechanical LBP [1] . The various causes of SIJ pain include previous trauma, inflammatory and degenerative etiology, degeneration of SIJ following fusion surgery, anterior dislocation, and multiple other causes [2] . Treatment for SIJ pain is often conservative and includes physiotherapy, nonsteroidal anti-inflammatory drugs (NSAIDs), and localized injections with steroids [3, 4] . If these conservative treatments fail, an alternative minimally invasive therapeutic option is radiofrequency (RF) denervation.
Radiofrequency denervation is a safe and effective procedure for treating SIJ pain [5] [6] [7] [8] . Thermal energy delivered by RF technologies can ablate tissue [9, 10] by delivery of a high-frequency electrical field (usually 100-1,000 kHz) from the tip of the RF probe [11] [12] [13] [14] [15] [16] [17] . The electrical field creates frictional forces that raise the temperature of the target tissue (>50 C) to enable tissue necrosis [11] [12] [13] [14] [15] [16] [17] . Radiofrequency ablation of nociceptive nerves emanating from a culprit pain source, such as the SIJ, can disrupt or reduce pain signal transmission to the central nervous system [10] .
Innervation of the SIJ is complex and highly variable [18, 19] . Contributions to SIJ innervation come from S1-S4 lateral branches as well as from L4 and L5 dorsal rami that together form the complex posterior sacral network (PSN) [20] [21] [22] [23] . These anatomical targets have been lesioned by RF to reduce pain derived from the SIJ [5] [6] [7] [8] 24] . Two devices are specifically designed for SIJ denervation: Simplicity III (NeuroTherm, Inc. Wilmington, MA, USA), a "conventional," non-watercooled RF device, and SInergy (Halyard Health, Inc., Alpharetta, GA, USA), a water-cooled device.
Apart from two previous investigations that, when taken together, provide conflicting recommendations concerning which RF denervation type is better for treating SIJ pain [24, 25] , there is no other study comparing cooled with conventional RF for SIJ-derived pain and, more specifically, no study comparing devices of these different RF denervation classes that are specifically designed to treat SIJ pain. Here, we present the results of our experience directly comparing Simplicity III to SInergy to treat SIJ pain and disability associated with it.
Methods

Study Patients
This was a retrospective observational study, with approval obtained from the ethical committee of Comitato Etico Provinciale (Brescia, Italy), and all patients provided written informed consent to use their outcomes in a report. This study was conducted in an Italian National Health Service public hospital. The patients considered for inclusion in this study were consecutively admitted to our clinic for chronic LBP lasting for at least six months.
Diagnosis of SIJ Pain
Diagnosis of SIJ-derived pain was made following the International Association for the Study of Pain (IASP) criteria [26] as follows: 1) patient had pain in the buttock or low back under L5, with radiation to the groin and/or thigh [3, 27] , 2) positivity of at least three out of six provocation tests for SIJ pain [27] , and 3) pain relieved by joint injection with anesthetic [26] . To diagnose SIJderived pain, we used an intra-articular test block, using ropivacaine 0.75% 2 mL, instead of a lateral branch block because lateral branch block is more timeconsuming and uncomfortable for patients and there is no clear evidence that lateral branch block is more predictive of a successful RF procedure [3] . Each test block with anesthetic was performed under fluoroscopic guidance using a 22 gauge, 100 mm spinal needle positioned in the lower third of the joint (Figure 1 ). Intra-articular spread of injected contrast medium was observed to confirm correct positioning of the needle.
Patients who experienced pain relief of 50% or greater within five hours of the test block were diagnosed with SIJ pain. A cutoff threshold of at least 50% pain reduction after test block was chosen according to previous studies [6, [28] [29] [30] , and moreover, in a study that compared treatment results between cutoff thresholds of 50% and 80%, no differences were found between RF denervation outcomes [24] .
Patients with pain radiating below the knee or over L5 were excluded from the study because based on either of these symptoms their pain generator was likely not the SIJ. Other possible sources of LBP were reasonably excluded (by means of physical exam, medical history, and magnetic resonance imaging/computed tomography/x-ray, as well as rheumatology screening, as required), including, but not limited to, bone fractures, the hip joint, symptomatic spondylolisthesis, tumor, and other regional soft tissue structures [28] .
Patients who were diagnosed with SIJ-derived pain were initially treated by conservative therapies, which consisted of multiple (up to three) injections (mean-¼ 2.2 6 0.5 SD per patient) in the SIJ with a local anesthetic (ropivacaine, 2 mg/injection), a steroid (methylprednisolone, 40 mg/injection), and regularly prescribed opioids and NSAIDs. Table 1 shows the distribution of patients in each study group by the number of SIJ injections they received.
Failure of therapeutic joint injections was defined as transient or unsustained efficacy (i.e., pain relief of 50% or greater [6, [28] [29] [30] lasting less than three months), while that of pharmacological therapy was indicated by its inability to provide substantial pain relief (i.e., 50%) [6, [28] [29] [30] or its ability to promote adverse events (e.g., nausea, constipation, cognitive impairment), which thus led patients to discontinue such medication use. Following failed conservative treatments, patients were subsequently scheduled for RF denervation.
The decision to use Simplicity III or SInergy was based on daily scheduling considerations (i.e., allotting time to perform RF procedures and ensure that each patient was monitored for four hours postprocedure prior to discharge) and device availability. Patients were not told which RF procedure would be used to treat them. Following their respective RF denervation treatment, patients used oral analgesics at their own discretion, with those who experienced satisfactory pain relief likely to stop such medication use and those who did not to continue. Exclusion criteria for SIJ denervation included patients who were 1) younger than age 18 years, 2) pregnant, or 3) mentally handicapped or had 1) a blood coagulation disorder, 2) infection at the intended site of intervention, or 3) an allergy to local anesthetics that were used. All procedures were performed under fluoroscopic guidance by the same operator. All patients were placed in the prone position, lightly sedated, with a pillow beneath the abdomen to reduce lumbar curvature, and skin at the intervention site was numbed with 2% lidocaine. After each procedure, the patient was observed for at least four hours before being discharged.
Simplicity III (Conventional RF) Procedure
Under fluoroscopic guidance, the SIJ was identified. The Simplicity III RF probe was inserted under the sacrum, about 1 cm lateral and 1 cm under S4. After reaching contact with the sacrum, the probe was positioned under fluoroscopic guidance lateral to the sacral foramen and medial to the joint line, with the tip of the probe reaching the sacral ala. Latero-lateral projection was used to ensure that the probe was close to the curvature of the bone ( Figure 2) . Next, sensory stimulation at 50 Hz was performed to elicit paresthesia under 0.8 volts (V) in the SIJ. Motor stimulation was conducted at 2 Hz, and at up to 1.5 V to verify no motor recruitment in the ipsilateral lower extremity. Denervation was performed as described previously [6] , which consisted of three monopolar lesions and two bipolar lesions at 85 C for 90 seconds each to form a strip lesion that included ablation of S1, S2, S3, and S4.
SInergy (Cooled RF) Procedure
Under fluoroscopic guidance, S1, S2, and S3 foramina were identified on the treatment side of the spine. A 17-gauge introducer needle was inserted lateral to the target foramen until contact with bone was achieved. Sensory and motor stimulation were conducted as described above for Simplicity III use. After stimulation, denervation by cooled RF was executed for 150 seconds at 60 C, as had previously been performed by Patel and colleagues [7, 8] . Three lesions at S1 and S2 and two lesions at S3 were created. Lesioning of the L5 dorsal ramus was achieved by positioning the needle between the junction of the sacral ala and S1 superior articular process (Figure 3 ) [7, 8] .
Outcome Measures
Patient-reported results for pain and physical function were noted as the primary outcomes of this study. Data were collected in a blinded fashion with respect to which RF type had been used on a particular patient by a single physician other than the one who performed the RF procedure. The numerical rating scale (NRS; range ¼ 0-10 points, 0 ¼ "no pain" and 10 ¼ "worst pain") [31] [32] [33] was used to assess pain. The RF procedure was considered a "treatment success" if the patient reported a follow-up NRS score relative to the respective baseline score that was reduced by 50% or more [34] . The Oswestry Disability Index (ODI; scale ¼ 0-100, 0 ¼ "no disability" and 100 ¼"worst disability") was used to assess the extent of disability associated with SIJ pain [35, 36] . The minimum clinically important difference (MCID) in ODI scores between baseline and each of the follow-up time points was a decrease of 15 or more points [37] , which was noted for each study group. Collection of ODI results involved completion by each patient of an extensive questionnaire, which was practical during their personal follow-up visits with the physician at one, six, and 12 months, but not at three months, when outcome feedback was provided instead by telephone interviews. Consequently, there are no three-month ODI outcome data available for presentation in this report. Assessments of the maintenance of both treatment success (NRS) and MCID (ODI) from one to 12 months' follow-up were used as measures of RF denervation durability. The secondary outcome of the study was the amount of time required to complete an RF procedure, from probe positioning until its removal. Additionally, procedure-related adverse events were recorded.
Statistical Analyses
Means and standard deviations were calculated for continuous demographic and primary outcome data, and, after absence of normal distribution was detected by the Kolmogorov-Smirnov test, means were compared by the Mann-Whitney test with P 0.01 indicating significant differences. Demographic categorical data (e.g., gender, subgroups defined as having previous back surgery) are expressed as number of patients in each study group, and were compared between groups by the Fisher's exact test at P 0.01. Outcome categorical data (i.e., subgroups defined by treatment success or MCID score change) are reported as percentages, followed by confidence intervals calculated at the 95% level, and were compared between study groups by the Fisher's exact test at P 0.01.
Results
Disposition of Study Subjects
The disposition of subjects who volunteered for this study is summarized in Figure 4 . Ninety percent of patients who met the criteria for SIJ denervation between January 2013 and January 2015 had the procedure performed by Simplicity III (49%) or SInergy (51%). Approximately 10% of eligible patients declined RF intervention for their SIJ pain and were instead managed by conservative treatments.
Demographics Table 2 shows the demographics and relevant baseline clinical features of patients by study group. The mean age of all study participants was 60.8 6 5.7 years. Twelve males and 31 females participated in the study, with the SInergy cohort having had twice the number of males as in the Simplicity III group, while the latter cohort had more females than the SInergy group. The body mass index in each study group was nearly equal, and the number of patients in each group who had previous back surgery (lumbar stabilization) was equivalent. The average duration of pain was 2.3 6 0.9 years, with that in the Simplicity III group being slightly longer than that in the SInergy group. There were no statistically significant differences between the study groups in any of the demographic characteristics or clinical features noted in Table 2 . Each patient used opioids until her/his respective RF denervation procedure (oxycodone/naloxone -mean ¼ 20 mg every 12 hours or tapentadolmean ¼ 100 mg every 12 hours) and/or NSAIDS (ibuprofen -mean¼ 600 mg/day or ETORICOXIB -mean ¼ 60 mg/ day), and continued to do so, as needed, after the denervation procedures were completed. throughout the study period were consistently less than those in the Simplicity III group, and at six and 12 months, the score differences were statistically significant (P < 0.01) between groups. The findings suggest that patients in the SInergy cohort experienced greater pain relief than those in the Simplicity III group at each follow-up time point, with the largest differences in analgesia occurring at six and 12 months.
Treatment successes (i.e., 50% reduction in NRS score at follow-up) [34] were achieved in the majority of the SInergy group at all follow-ups, while outcome successes occurred in the Simplicity III cohort in greater than 50% of the cohort at one and three months, but well-below this demarcation at six and 12 months ( Figure 6 ). Differences in treatment success proportions between study groups were statistically significant (P < 0.01) at six and 12 months, having values of approximately 40% and 50%, respectively. These results suggest that a greater proportion of patients in the SInergy group experienced more SIJ analgesia than that in the Simplicity III cohort at each follow-up, especially at six and 12 months.
A study measure of RF denervation durability was maintenance of a patient's treatment success status from one to 12 months of follow-up. Thus, 25% (5/20) of the Simplicity III members who were treatment successes at one month retained this status at 12 months ( Figure 7A ). In contrast, 68% (16/22) of SInergy group members who achieved treatment success at one month were also in this subgroup at 12 months ( Figure 7B ). At 12 months, Simplicity III group members reported NRS scores that had increased (i.e., moved back toward baseline values) by an average of 50% (range ¼ 25-86%) relative to their one-month treatment success scores; this includes one patient who improved from one to 12 months, having NRS score reductions from baseline of 67% and 78% at these follow-up time points, respectively. In the SInergy group, 12-month NRS scores increased relative to their one-month treatment success scores by 36% on average (range ¼ 11-80%).
Overall, three members of the Simplicity III group had NRS scores that reverted to baseline by 12 months, after having had scores at all earlier time points that indicated a response, including those that qualified as treatment successes at one and three months' followup. No other patients from either RF treatment group had NRS scores equivalent to their former baseline scores at any follow-up time point.
Disability
Data displayed in Figure 8 illustrate that the mean baseline Simplicity III group ODI score was insignificantly greater than that of the SInergy group. The mean ODI score changes with time in each study group followed patterns similar to what was observed for the mean NRS scores in that there were dramatic mean ODI score reductions at one month, followed by average score increases at each succeeding time point. The mean ODI scores of the SInergy group were consistently less than those of the Simplicity III cohort at each time point, with statistically significant (P 0.01) differences observed at six and 12 months. The findings suggest Figure 4 Disposition of study subjects. SIJ ¼ sacroiliac joint. that patients in the SInergy cohort experienced greater relief from disability than those in the Simplicity III group at each follow-up time point, with the largest improvement differences occurring at six and 12 months.
The proportion of the SInergy cohort that had ODI score decreases that were greater than or equal to the MCID (15 points) [37] was nearly 100% at one month and remained the same at the six-and 12-month follow-ups ( Figure 9 ). While nine of 10 members of the Simplicity III group had ODI score changes that were at least the MCID at one month, this proportion consistently declined at each succeeding follow-up time point, with the SInergy proportions exceeding those of the Simplicity III group by approximately 20% and 35%, respectively, at six and 12 months. These results suggest that a greater proportion of patients in the SInergy group experienced relief from disability than that in the Simplicity III cohort at each follow-up, especially at six and 12 months.
Another study measure of RF denervation durability was maintenance of ODI score drops that were greater than or equal to 15 points, the MCID for this outcome [37] . As such, 68% (13/19) of the Simplicity III group members who had ODI score decreases that were greater than or equal to the MCID at one month retained this status at 12 months ( Figure 10A ). In contrast, 100% (21/21) of SInergy group members who had such score changes at one month also had them at 12 months ( Figure 10B ). At 12 months, ODI scores increased (i.e., moved back toward baseline) relative to one-month MCID scores by an average of 16 points (range ¼ 9--24 points) in the Simplicity III group; this includes one patient who improved from one to 12 months, having ODI score reductions from baseline of 16 and 22 at these follow-up time points, respectively. This patient was the same as the one whose NRS score had improved from one to 12 months ( Figure 7A ). In the SInergy group, the average ODI score increase at 12 months relative to one-month MCID scores was 10 points (range ¼ 0--18 points).
In the entire SInergy group, six patients had NRS scores that did not qualify them as being treatment successes at 12 months, and of those six patients, five (83%) had ODI score reductions at 12 months that met or surpassed the MCID. Sixteen patients in the Simplicity III group had NRS scores at 12 months that failed to qualify them as treatment successes, and of those 16 patients, eight (50%) had ODI score declines at 12 months that surpassed the MCID. One patient in the SInergy group and eight patients in the Simplicity III group did not meet the treatment success or MCID score decrease at 12 months.
Secondary Outcomes
Denervation by Simplicity III occurred for a mean period of 19.4 6 8.2 (SD) minutes per patient, while SInergy required a mean duration of 48.8 6 9.6 minutes.
Procedure-Related Complications
One patient treated by SInergy had transient leg pain that could be related to postprocedure neuritis. The pain resolved after a one-week treatment with oral Figure 5 Mean numerical rating scale (NRS) values of each study group at each follow-up time point. Numbers in columns indicate exact mean NRS scores, and underlined numbers indicate P values. The "whiskers extending" from columns (means) are standard deviations. *Denotes significant differences (Mann-Whitney test, significance at P 0.01) between study groups at the applicable time point.
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steroids. No complications were reported in the Simplicity III study group.
Discussion
This study is the first to directly compare these specific conventional (Simplicity III) and cooled (SInergy) RF devices for their effectiveness and safety in treating SIJ pain and disability associated with it. While primary outcomes of these RF modalities were insignificantly different up to three months' follow-up, SInergy was superior in both pain and disability outcomes at six and 12 months. Furthermore, when short-term (one-month) treatment successes and MCID-qualified disability score changes occurred in each group, those in the SInergy group were durable (lasted up to 12 months) more often compared with those in the Simplicity III cohort. These results provide novel evidence that these specific RF devices afford different long-term outcomes regarding treatment of SIJ pain and disability and buttress previously published data that demonstrated long-term (12-month) clinically relevant effects of SInergy in a randomized, placebo-controlled trial on patients suffering from SIJ pain and disability [8] . In addition, the effects of Simplicity III on SIJ-derived pain in this current study were comparable with those previously reported by Schmidt at 12 months [38] and Bellini and Barbieri at one, three, and 12 months [6] .
Previous studies reported mean pain and disability scores to convey outcomes [6] [7] [8] 24, 25, [28] [29] [30] 38] .
When mean values of a study group are used to express treatment outcomes, such treatments are significantly effective if all patients consistently benefit to some degree or if a substantial majority of patients benefit to at least a moderate degree [39] . Therefore, study group means indicating no statistical significance can result from relatively poor responses derived from a majority fraction of the group and can mask highly favorable responses within a minority fraction [39] . We addressed these caveats by providing categorical data for pain (NRS) and disability (ODI) in Figures 6 and 9 and individual data plots of these outcomes for each patient in Figures 7 and 10 to complement the displays of pain and disability mean outcomes in Figures 5 and  8 , respectively.
In our pain center, we perform approximately 30 RF denervations of the SIJ annually with use of both of the devices studied here. Simplicity III and SInergy are the only two RF devices specifically designed to treat SIJ pain, and reports show that each of these devices has high success rates for treating SIJ discomfort [6] [7] [8] 24, 25, [28] [29] [30] 38] . Cheng et al. observed no differences between conventional RF and cooled RF devices in the duration of SIJ pain relief as both RF options provided greater than 50% pain reduction for three to six months in most patients studied [25] . A caveat Figure 6 Proportions of treatment successes in each study group, expressed as a percentage of each population, at each follow-up time point. "Treatment success" is defined as a patient having a follow-up numerical rating score (NRS) reduction 50% of the respective baseline NRS score. Numbers in columns indicate exact percentages, and underlined values indicate P values. *Denotes significant difference (Fisher's exact test, significance at P 0.01) between study groups at the applicable time point. The one-month, three-month, six-month, and 12-month 95% confidence intervals are Simplicity III [85. proportions at one month to 12 months in each study group were measures of RF denervation durability. "Treatment success" is defined as a patient having a follow-up NRS score relative to respective baseline score that is reduced by 50%. Figure 8 Mean Oswestry Disabilty Index (ODI) values of each study group at each follow-up time point. Numbers in columns indicate exact mean ODI scores, and underlined numbers indicate P values. The "whiskers extending" from columns (means) are standard deviations. *Denotes significant differences (Mann-Whitney test, significance at P 0.01) between study groups at the applicable time point. Figure 10 Durability of disability relief provided by radiofrequency (RF) denervation. Comparisons of ODI score changes achieving MCIDs at one month to 12 months in each study group were measures of RF denervation durability of disability relief. The MCID for the ODI is a score decrease at follow-up that is 15 points relative to the respective baseline score.
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concerning that examination, however, is that more patients treated by cooled RF had previous back surgery, a factor that may be predictive of a negative outcome [24] . Additionally, the patient groups did not compare well regarding age, gender, prior back procedures (i.e., fusions), and RF treatment procedure (L4 was not consistently targeted). In a comparative retrospective study of SIJ denervation, cooled RF was associated with a higher percentage of positive outcomes compared with conventional RF [24] . However, neither of these two studies investigated the use of Simplicity III as the conventional RF device.
In addition to the bony landscape of the sacrum being highly variable [40] , innervation of the SIJ is complex and variable [18, 19] . Two studies that analyzed SIJ innervation in cadavers had different conclusions. Roberts and colleagues studied 25 cadaveric hemipelves and reported that S1-S2 contributed to the PSN in 100% of specimens, S3 in 88%, L5 in 8%, and S4 in 4% [18] . In contrast, based on their examination of 12 cadaveric hemipelves, Cox reported that L5 contributed to the PSN in 75% of cadavers observed [19] . Moreover, Dreyfuss indicated that a multisite, multidepth approach is required to effectively anesthetize the SIJ complex [41] . Together, the results of these investigations show that SIJ innervation has a high degree of variability, which may have significant implications for RF denervation.
Simplicity III consists of a tripolar probe, with the combination of the three electrodes creating five lesions, three monopolar and two bipolar, resulting in a strip lesion with a single insertion point [6] . A retrospective study of 11 patients treated with Simplicity III showed a mean reduction in pain intensity of 61% over 12 months [28] . In addition, a large case series described by Bellini involved 102 lesions made in 60 patients with over 90% treatment success at one month and persistence of analgesia in 35% of patients at the one-year follow-up [6] . The Simplicity III probe is characterized by a fixed degree of bending and length that is designed to adapt to the sacral curvature of the human spine. However, as indicated above, there is significant variation in the shape and structure of the sacrum itself, both between sacral sides of the same patient and among different patients [40] . Consequently, the fixed geometry of the probe does not fit all variations in sacral curvature and innervation found in patients. The combination of mono and bipolar lesions create a single strip lesion along the joint line [6] , theoretically ablating all nerves exiting from sacral foramina, but the depth of lesioning cannot be adjusted. Moreover, the Simplicity III probe does not permit direct lesioning of the L5 dorsal ramus. In fact, some authors have performed additional lesioning of the L5 dorsal ramus with a separate RF needle [28] .
In contrast to Simplicity III, the SInergy probe can be positioned with greater flexibility and enables direct lesioning of the L5 dorsal ramus [7, 8] . Water cooling enables SInergy to operate at a lower probe tip temperature than that of conventional RF devices (60 C compared with 80-90 C). Cooling removes heat from tissue immediately surrounding the tip of the SInergy probe, thereby preventing formation of necrotic tissue in that localized area and the potential for high impedance associated with it. The relatively low impedance around the probe allows RF energy emitted by SInergy to create a bigger lesion compared with that made by conventional RF [42] , therefore making it more likely that cooled RF (i.e., SInergy) will denervate the culprit variably positioned SIJ nociceptive nerve tracks among patients. Denervation of the SIJ with SInergy consists of three lesions made lateral to S1 and S2, two lesions lateral to S3, and a single lesion at the L5 dorsal ramus [7, 8] . Patel reported that greater than 50% of study subjects treated by SInergy experienced at least a 50% decrease in SIJ pain at 12 months [8] . Cooled RF may be one of the most effective modalities of SIJ denervation, given that relief from SIJ pain lasted up to two years postprocedure in 75% of patients [29] . In a systematic review of the effectiveness of SIJ interventions, Simopoulos et al. [5] indicated that the evidence for cooled RF neurotomy in managing SIJ pain is levels 2 to 3 [43] , while evidence for conventional RF is levels 3 or 4 [43] . In this study, primary pain outcomes following each RF procedure were equivalent up to three months, but significant disparities in pain and disability results were evident at subsequent follow-ups. Basic studies are required to determine whether such relatively long-term effectiveness differences are due to SInergy's presumed enhanced ability to "hit" targeted nerves, make larger lesions on target nerves, or both.
Our results indicate that RF ablation is an effective and safe technique for managing SIJ pain and associated disability. Both devices had a high degree of relatively short-term effectiveness, in that 90% of patients in each study group were treatment successes at one-and three-month follow-up. The NRS scores recorded throughout the entire study, however, suggest that patients treated by SInergy experienced greater pain relief, and for a longer period of time, compared with patients treated by Simplicity III. Long-term improvements in disability, as measured by the ODI scale, again favored SInergy, as the ODI scores in this group were significantly lower than those in the Simplicity III group throughout, and significantly so at six and 12 months. Like SInergy-induced pain relief, it was more likely that a patient who experienced relief from disability at one month would continue to experience such a benefit throughout the entire study period than a patient who was treated by Simplicity III. Interestingly, achievement of ODI score reductions that met or surpassed the MCID for this outcome did not always occur in a patient considered to be a treatment success at 12 months. Conventional thinking suggests that pain alleviation facilitates better function. However, these results infer that pain relief of less than 50% may be enough for some patients, especially if they have a relatively high tolerance for pain, to function in a manner that they deem to be satisfactory.
Whereas procedure time was significantly shorter when Simplicity III was used, this finding may aid physicians to select an RF denervation source for patients according to their tolerance for remaining in the prone position for no longer than approximately 20 minutes or in bilateral procedures. Finally, the nominal complication history in this study is a testament to the safety of these RF techniques for treating SIJ pain and is consistent with former reports that observed few minor adverse events associated with RF denervation of the SIJ [6] [7] [8] 24, 25, [28] [29] [30] .
Limitations
This was not a prospective randomized controlled clinical trial, and so this retrospective investigation was prone to biases, such as physician awareness of which RF technique was used to treat each patient. Without a control group component, patients had no possibility to receive what they may have deemed to be an ineffective placebo treatment, therefore perhaps prompting them to artificially make their responses to their respective RF treatments more positive than if a placebo treatment was included in the study. Within this study design, assessments of opioid use, and depression evaluations pre-and post-RF procedures as potential correlates to opioid use, may have been useful given the strong interest among health care workers and patients to reduce intake of these potentially addictive drugs.
Conclusions
The conventional (Simplicity III) and cooled (SInergy) RF devices used in the study were both effective and safe for treating SIJ pain and its associated disability in the short term (through three months). The presumed ability of SInergy (cooled RF) to create larger lesions than those by Simplicity III (conventional RF) [42] in this study population may have enabled more complete denervation of the SIJ by SInergy and thus may account for the greater and longer-lasting postprocedure pain relief observed throughout the study compared with denervation by Simplicity III. The significant analgesic effect of SInergy compared with Simplicity III at six and 12 months suggests that SInergy is favorable for offering patients relatively long-term pain relief and disability improvements. Simplicity III may be a more suitable treatment than SInergy for bilateral procedures when denervation is required to be performed in a single session (i.e., at a patient's request), and for patients who have limited tolerance to be in a procedure-required prone position. Further investigations that can eliminate the possibilities of procedure selection bias by physicians, including a control group, and evaluate the impact of these RF procedures on opioid use are needed to confirm what is suggested by this current report, which is that SInergy is the preferred RF denervation option for treating SIJ pain and the disability associated with it.
